XIAP and colorectal cancer: Our published studies have revealed that X‐link inhibitor of apoptosis protein (XIAP), through its RING domain, is able to associate with RhoGDIα and inhibit RhoGDIα SUMOylation, by which XIAP inhibits colorectal cancer cell mobility (Fang et al., 2012).